Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Perspectives

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package

       
Total article views   HTML views PDF downloads Totals
11,158 Dovepress* 9,946+ 2,084 12,030
PubMed Central* 1,212 420 1,632
Totals 11,158 2,504 13,662
*Since 6 December 2012
+Since July 2016

View citations on PubMed Central and Google Scholar